InMed Pharmaceuticals Inc. sell tinelchen
Start price
30.11.21
/
0%
€39.25
Target price
30.11.22
-
Performance (%)
-17.83%
End price
12.12.21
€32.25
Summary
This prediction ended on 12.12.21 with a price of €32.25. The prediction for InMed Pharmaceuticals Inc. closed with a convincing performance of -17.83%. This prediction was marked as speculative and is excluded from tinelchen's performance statistics.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| InMed Pharmaceuticals Inc. | 3.529% | 3.529% | -80.180% |
| iShares Core DAX® | 0.476% | -0.039% | 13.342% |
| iShares Nasdaq 100 | 1.290% | 0.504% | 40.099% |
| iShares Nikkei 225® | 1.300% | -2.135% | 19.861% |
| iShares S&P 500 | 0.829% | 0.193% | 29.756% |
According to tinelchen what are the pros and cons of InMed Pharmaceuticals Inc. for the foreseeable future?
Pros
Cons
Probably not worthwhile Investment
Comments by tinelchen for this prediction
In the thread Inmed Pharmaceuticals Inc. diskutieren
Sell InMed Pharmaceuticals Inc.